Cargando…
Symptom Profile of Patients With Post-COVID-19 Conditions and Influencing Factors for Recovery
BACKGROUND: The aim of the study was to examine the factors that influence the improvement of post-coronavirus disease 2019 (COVID-19) symptoms. METHODS: We investigated the biomarkers and post-COVID-19 symptoms status of 120 post-COVID-19 symptomatic outpatients (44 males and 76 females) visiting o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990724/ https://www.ncbi.nlm.nih.gov/pubmed/36895625 http://dx.doi.org/10.14740/jocmr4855 |
_version_ | 1784901995305369600 |
---|---|
author | Matsuoka, Norihiro Mizutani, Takuo Kawakami, Koji |
author_facet | Matsuoka, Norihiro Mizutani, Takuo Kawakami, Koji |
author_sort | Matsuoka, Norihiro |
collection | PubMed |
description | BACKGROUND: The aim of the study was to examine the factors that influence the improvement of post-coronavirus disease 2019 (COVID-19) symptoms. METHODS: We investigated the biomarkers and post-COVID-19 symptoms status of 120 post-COVID-19 symptomatic outpatients (44 males and 76 females) visiting our hospital. This study was a retrospective analysis, so we analyzed the course of symptoms only for those who could follow the progress of the symptoms for 12 weeks. We analyzed the data including the intake of zinc acetate hydrate. RESULTS: The main symptoms that remained after 12 weeks were, in descending order: taste disorder, olfactory disorder, hair loss, and fatigue. Fatigue was improved in all cases treated with zinc acetate hydrate 8 weeks later, exhibiting a significant difference from the untreated group (P = 0.030). The similar trend was observed even 12 weeks later, although there was no significant difference (P = 0.060). With respect to hair loss, the group treated with zinc acetate hydrate showed significant improvements 4, 8, and 12 weeks later, compared with the untreated group (P = 0.002, P = 0.002, and P = 0.006). CONCLUSION: Zinc acetate hydrate may improve fatigue and hair loss as symptoms after contracting COVID-19. |
format | Online Article Text |
id | pubmed-9990724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99907242023-03-08 Symptom Profile of Patients With Post-COVID-19 Conditions and Influencing Factors for Recovery Matsuoka, Norihiro Mizutani, Takuo Kawakami, Koji J Clin Med Res Original Article BACKGROUND: The aim of the study was to examine the factors that influence the improvement of post-coronavirus disease 2019 (COVID-19) symptoms. METHODS: We investigated the biomarkers and post-COVID-19 symptoms status of 120 post-COVID-19 symptomatic outpatients (44 males and 76 females) visiting our hospital. This study was a retrospective analysis, so we analyzed the course of symptoms only for those who could follow the progress of the symptoms for 12 weeks. We analyzed the data including the intake of zinc acetate hydrate. RESULTS: The main symptoms that remained after 12 weeks were, in descending order: taste disorder, olfactory disorder, hair loss, and fatigue. Fatigue was improved in all cases treated with zinc acetate hydrate 8 weeks later, exhibiting a significant difference from the untreated group (P = 0.030). The similar trend was observed even 12 weeks later, although there was no significant difference (P = 0.060). With respect to hair loss, the group treated with zinc acetate hydrate showed significant improvements 4, 8, and 12 weeks later, compared with the untreated group (P = 0.002, P = 0.002, and P = 0.006). CONCLUSION: Zinc acetate hydrate may improve fatigue and hair loss as symptoms after contracting COVID-19. Elmer Press 2023-02 2023-02-28 /pmc/articles/PMC9990724/ /pubmed/36895625 http://dx.doi.org/10.14740/jocmr4855 Text en Copyright 2023, Matsuoka et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Matsuoka, Norihiro Mizutani, Takuo Kawakami, Koji Symptom Profile of Patients With Post-COVID-19 Conditions and Influencing Factors for Recovery |
title | Symptom Profile of Patients With Post-COVID-19 Conditions and Influencing Factors for Recovery |
title_full | Symptom Profile of Patients With Post-COVID-19 Conditions and Influencing Factors for Recovery |
title_fullStr | Symptom Profile of Patients With Post-COVID-19 Conditions and Influencing Factors for Recovery |
title_full_unstemmed | Symptom Profile of Patients With Post-COVID-19 Conditions and Influencing Factors for Recovery |
title_short | Symptom Profile of Patients With Post-COVID-19 Conditions and Influencing Factors for Recovery |
title_sort | symptom profile of patients with post-covid-19 conditions and influencing factors for recovery |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990724/ https://www.ncbi.nlm.nih.gov/pubmed/36895625 http://dx.doi.org/10.14740/jocmr4855 |
work_keys_str_mv | AT matsuokanorihiro symptomprofileofpatientswithpostcovid19conditionsandinfluencingfactorsforrecovery AT mizutanitakuo symptomprofileofpatientswithpostcovid19conditionsandinfluencingfactorsforrecovery AT kawakamikoji symptomprofileofpatientswithpostcovid19conditionsandinfluencingfactorsforrecovery |